Publications by authors named "Yosuke Saka"

Claim this Profile
S
Serum zinc level is associated with aortic arch calcification in incident dialysis patients.
Yosuke Saka, Tomohiko Naruse, Yuichi Katsurayama, Yuki Sato, Shun Ito

J Nephrol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between primary care physician-nephrologist collaboration and clinical outcomes in patients with stage 5 chronic kidney disease: a JOINT-KD cohort study.
Minoru Murakami, Takuya Aoki, Yoshifumi Sugiyama, Sho Sasaki, Hiroki Nishiwaki, Yosuke Saka

J Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recipients of public assistance with advanced chronic kidney disease: insights into receiving a presentation of kidney replacement therapy options and polypharmacy from Japanese investigators with innovative network about kidney disease study.
Yoshihiro Nakamura, Sho Sasaki, Takahiro Imaizumi, Hiroki Nishiwaki, Minoru Murakami, Yosuke Saka

Clin Exp Nephrol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacubitril/valsartan reduces proteinuria depending on blood pressure in patients with stage 4-5 chronic kidney disease.
Yosuke Saka, Hiroshi Takahashi, Tomohiko Naruse, Yuzo Watanabe

Clin Exp Nephrol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Adipose-Derived Mesenchymal Stem Cell (ADR-001) Therapy for IgA Nephropathy.
Akihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda, Asuka Horinouchi, Kayaho Maeda, Yosuke Saka

Kidney360· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association between High-Dose Allopurinol and Erythropoietin Hyporesponsiveness in Advanced Chronic Kidney Disease: JOINT-KD Study.
Megumi Oikawa, Hiroki Nishiwaki, Takeshi Hasegawa, Sho Sasaki, Masahiko Yazawa, Yosuke Saka

Nephron· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of pauci-immune necrotizing glomerulonephritis during pembrolizumab treatment.
Jun Matsumoto, Yosuke Saka, Tomohiko Naruse

Clin Exp Nephrol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Proton Pump Inhibitor Therapy Increases the Risk of Infection in Patients with Incident Hemodialysis.
Yosuke Saka, Tomohiko Naruse, Taiki Chikamatsu, Kotaro Mitani, Mako Hayashi

Nephron· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of SARS-CoV-2 antigen positivity in hemodialysis patients.
Jun Matsumoto, Yosuke Saka, Tetsushi Mimura, Tomohiko Naruse

Ren Fail· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS).
Tomonori Kimura, Ryohei Yamamoto, Mitsuaki Yoshino, Ryuichi Sakate, Enyu Imai, Yosuke Saka, Yoshitaka Isaka

Clin Exp Nephrol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Kidney Injury and Remission of Proteinuria in Minimal Change Disease.
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Yosuke Saka, Isaka Yoshitaka

Kidney Int Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cases of ceftriaxone-induced encephalopathy treated by hemoperfusion in hemodialysis patients.
Chikao Onogi, Akinori Osada, Kentaro Imai, Tetsushi Mimura, Yosuke Saka

Hemodial Int· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study.
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Yosuke Saka, Yoshitaka Isaka

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Yosuke Saka, Yoshitaka Isaka

J Nephrol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a Phase 1, Open-Label, Multiple-Center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 in the Treatment of Immunoglobulin A Nephropathy.
Akihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda, Kayaho Maeda, Shoji Saito, Yosuke Saka

Front Med (Lausanne)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Serum Zinc Concentration Is Associated With Infection Particularly in Patients With Stage 5 Chronic Kidney Disease Medicated with Proton Pump Inhibitors.
Yosuke Saka, Tomohiko Naruse, Jun Matsumoto, Yuka Takeda, Chikao Onogi

J Ren Nutr· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose-response, phase 2/3 study.
Naoki Kashihara, Toshiki Nishio, Takeshi Osonoi, Yosuke Saka, Toshiyuki Imasawa

Clin Exp Nephrol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS).
Hitoshi Yokoyama, Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Sugiyama, Yosuke Saka, Yoshitaka Isaka

Clin Exp Nephrol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Yosuke Saka, Yoshitaka Isaka

Clin Exp Nephrol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute azotaemia without serum cystatin C elevation.
Yosuke Saka, Akihisa Kato, Naoto Tawada, Yuhei Noda, Syunsuke Niwa

Nephrology (Carlton)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Yosuke Saka, Yoshitaka Isaka

Clin Exp Nephrol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renoprotective effects of topiroxostat for Hyperuricaemic patients with overt diabetic nephropathy study (ETUDE study): A prospective, randomized, multicentre clinical trial.
Toshihiro Mizukoshi, Sawako Kato, Masahiko Ando, Hiroshi Sobajima, Norimi Ohashi, Yosuke Saka

Nephrology (Carlton)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiamine status in end-stage chronic kidney disease patients: a single-center study.
Yosuke Saka, Tomohiko Naruse, Akihisa Kato, Naoto Tawada, Yuhei Noda

Int Urol Nephrol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.
Yuhei Noda, Yosuke Saka, Akihisa Kato, Tetsushi Mimura, Tomohiko Naruse

Clin Nephrol Case Stud· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life of elderly patients on peritoneal dialysis versus hemodialysis: a single-center study.
Yosuke Saka, Tomohiko Naruse, Naoto Tawada, Mitsuhiro Tokomoto, Yuhei Noda

Clin Exp Nephrol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis